OpportunityTitle: Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
AdditionalInformationOnEligibility: This is a single-eligibility award. Only the University of Pittsburgh, the institution with the existing National Mesothelioma Virtual Bank for Translational Research, is eligible to apply.
Description: The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in fiscal year 2006 to serve as an exceptional resource for mesothelioma research. RFA-OH-21-007 will continue the NMVB to advance biomedical research for malignant mesothelioma to gain a better understanding of the disease and its progression, and the potential development of new treatments, therapeutics, and diagnostics for mesothelioma. Continued support to the NMVB will allow expansion of collection of biospecimens, related data, and other information. NIOSH intends to continue the NMVB at the University of Pittsburgh to accomplish the following important program priorities: maintain uninterrupted assistance to mesothelioma researchers; avoid critical support gaps for current or pending mesothelioma research efforts; demonstrate a sustained public health commitment to advancing the treatment of mesothelioma; and affirm a sustained commitment to workers and other people impacted by this disease.
GrantorContactEmailDescription: beg8@cdc.gov
GrantorContactText: BRIDGETTE GARRETT&lt;br/&gt;beg8@cdc.gov
CloseDateExplanation: Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information it contains allows CDC staff to plan the review. By the date listed above and in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:  Name of the Applicant Descriptive title of proposed research Name, address, and telephone number of the PD(s)/PI(s) Names of other key personnel Participating institutions Number and title of this funding opportunity  The letter of intent should be sent to: Michael Goldcamp, Ph.D. National Institute for Occupational Safety and Health Centers for Disease Control and Prevention Telephone: 304-285-5951 Email: MGoldcamp@cdc.gov